Intranasal oxytocin in eighteen hundred patients. A study on its safety as used in a community hospital.
D000336:Aerosols; D001034:Apgar Score; D005260:Female; D005313:Fetal Death / Q000139:chemically induced / Q000453:epidemiology*; D005315:Fetal Diseases / Q000139:chemically induced / Q000453:epidemiology*; D006769:Hospitals, General; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced; D008722:Methods; D010121:Oxytocin / Q000008:administration & dosage* / Q000009:adverse effects*; D010298:Parity; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced / Q000453:epidemiology*; D012189:Retrospective Studies; D012996:Solutions
D000336:Aerosols; D012996:Solutions; D010121:Oxytocin